eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | myeloid leukemia |
| Comorbidity | C0022661|chronic renal failure |
| Sentences | 1 |
| PubMedID- 25600167 | Objective: to determine the potential for arsenic trioxide (ato) to be safely and effectively incorporated into induction therapy of newly diagnosed acute promyelocytic leukaemia (apl) in patients with severe chronic renal failure (crf) by reduction of the ato dosage to compensate for reduced renal elimination of arsenic in crf. |
Page: 1